Balchem [BCPC] vs NewMarket [NEU] Detailed Stock Comparison
Balchem
NASDAQ
Loading...
NewMarket
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Balchem wins in 4 metrics, NewMarket wins in 16 metrics, with 0 ties. NewMarket appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Balchem | NewMarket | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 32.38 | 16.98 | NewMarket |
| Price-to-Book Ratio | 3.61 | 5.00 | Balchem |
| Debt-to-Equity Ratio | 16.38 | 56.98 | Balchem |
| PEG Ratio | 1.68 | 9.40 | Balchem |
| EV/EBITDA | 19.42 | 11.54 | NewMarket |
| Profit Margin (TTM) | 14.48% | 17.28% | NewMarket |
| Operating Margin (TTM) | 20.30% | 22.37% | NewMarket |
| EBITDA Margin (TTM) | 20.30% | 22.37% | NewMarket |
| Return on Equity | 11.99% | 33.74% | NewMarket |
| Return on Assets (TTM) | 7.66% | 12.86% | NewMarket |
| Free Cash Flow (TTM) | $146.34M | $462.27M | NewMarket |
| Dividend Yield | 0.54% | 1.19% | NewMarket |
| 1-Year Return | -18.53% | 48.35% | NewMarket |
| Price-to-Sales Ratio (TTM) | 4.65 | 2.90 | NewMarket |
| Enterprise Value | $4.72B | $8.90B | NewMarket |
| EV/Revenue Ratio | 4.79 | 3.20 | NewMarket |
| Gross Profit Margin (TTM) | 36.45% | 31.63% | Balchem |
| Revenue per Share (TTM) | $30 | $293 | NewMarket |
| Earnings per Share (Diluted) | $4.36 | $50.48 | NewMarket |
| Beta (Stock Volatility) | 0.92 | 0.47 | NewMarket |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Balchem vs NewMarket Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Balchem | 3.09% | -4.07% | -11.47% | -13.68% | -12.11% | -11.53% |
| NewMarket | 0.57% | -6.81% | -5.43% | 6.45% | 41.76% | 52.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Balchem | -18.53% | 11.07% | 33.21% | 106.02% | 354.19% | 1,653.75% |
| NewMarket | 48.35% | 153.62% | 111.90% | 105.37% | 553.86% | 4,828.53% |
News Based Sentiment: Balchem vs NewMarket
Balchem
News based Sentiment: MIXED
Balchem experienced a mixed month, with positive Q2 earnings and an analyst upgrade countered by a 52-week low and bearish technical signals. This creates a complex investment picture, making October a significant month for the company's trajectory.
NewMarket
News based Sentiment: MIXED
NewMarket had a busy month with a significant acquisition, consistent dividend payments, and a new 52-week high. However, mixed analyst sentiment and varied institutional investor activity create a somewhat uncertain outlook, making it a moderately important month for investors.
Performance & Financial Health Analysis: Balchem vs NewMarket
| Metric | BCPC | NEU |
|---|---|---|
| Market Information | ||
| Market Cap | $4.66B | $8.24B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 137,710 | 102,690 |
| 90 Day Avg. Volume | 154,037 | 95,090 |
| Last Close | $144.64 | $783.65 |
| 52 Week Range | $139.17 - $185.96 | $480.00 - $875.97 |
| % from 52W High | -22.22% | -10.54% |
| All-Time High | $186.03 (Jul 29, 2024) | $875.97 (Oct 08, 2025) |
| % from All-Time High | -22.25% | -10.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | -0.02% |
| Quarterly Earnings Growth | 0.19% | 0.00% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.17% |
| Operating Margin (TTM) | 0.20% | 0.22% |
| Return on Equity (TTM) | 0.12% | 0.34% |
| Debt to Equity (MRQ) | 16.38 | 56.98 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $39.07 | $171.52 |
| Cash per Share (MRQ) | $2.02 | $7.48 |
| Operating Cash Flow (TTM) | $187.33M | $583.18M |
| Levered Free Cash Flow (TTM) | $126.15M | $451.67M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.54% | 1.19% |
| Last 12-Month Dividend | $0.87 | $7.75 |
Valuation & Enterprise Metrics Analysis: Balchem vs NewMarket
| Metric | BCPC | NEU |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 32.38 | 16.98 |
| Forward P/E | 28.93 | 33.20 |
| PEG Ratio | 1.68 | 9.40 |
| Price to Sales (TTM) | 4.65 | 2.90 |
| Price to Book (MRQ) | 3.61 | 5.00 |
| Market Capitalization | ||
| Market Capitalization | $4.66B | $8.24B |
| Enterprise Value | $4.72B | $8.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.79 | 3.20 |
| Enterprise to EBITDA | 19.42 | 11.54 |
| Risk & Other Metrics | ||
| Beta | 0.92 | 0.47 |
| Book Value per Share (MRQ) | $39.07 | $171.52 |
Financial Statements Comparison: Balchem vs NewMarket
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BCPC | NEU |
|---|---|---|
| Revenue/Sales | $255.47M | $698.51M |
| Cost of Goods Sold | $162.35M | $477.56M |
| Gross Profit | $93.11M | $220.95M |
| Research & Development | $4.30M | $32.37M |
| Operating Income (EBIT) | $51.44M | $143.15M |
| EBITDA | $63.18M | $186.92M |
| Pre-Tax Income | $49.01M | $147.69M |
| Income Tax | $10.73M | $36.44M |
| Net Income (Profit) | $38.28M | $111.24M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BCPC | NEU |
|---|---|---|
| Cash & Equivalents | $49.90M | $118.25M |
| Total Current Assets | $340.24M | $1.12B |
| Total Current Liabilities | $139.56M | $396.26M |
| Long-Term Debt | $204.14M | $1.05B |
| Total Shareholders Equity | $1.21B | $1.52B |
| Retained Earnings | $1.03B | $1.48B |
| Property, Plant & Equipment | $340.80M | $809.78M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BCPC | NEU |
|---|---|---|
| Operating Cash Flow | $38.04M | $146.90M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $30.90M | $107.30M |
| Debt Repayment | $-29.05M | $-50.00M |
| Common Stock Repurchase | $-5.33M | $-57.06M |
Short Interest & Institutional Ownership Analysis
| Metric | BCPC | NEU |
|---|---|---|
| Shares Short | 425,613 | 161,576 |
| Short Ratio | 3.01 | 1.63 |
| Short % of Float | 0.02% | 0.02% |
| Average Daily Volume (10 Day) | 137,710 | 102,690 |
| Average Daily Volume (90 Day) | 154,037 | 95,090 |
| Shares Outstanding | 32.53M | 9.52M |
| Float Shares | 32.28M | 7.78M |
| % Held by Insiders | 0.00% | 0.27% |
| % Held by Institutions | 0.91% | 0.66% |
Dividend Analysis & Yield Comparison: Balchem vs NewMarket
| Metric | BCPC | NEU |
|---|---|---|
| Last 12-Month Dividend | $0.87 | $7.75 |
| Last 12-Month Dividend Yield | 0.54% | 1.19% |
| 3-Year Avg Annual Dividend | $0.79 | $8.60 |
| 3-Year Avg Dividend Yield | 0.55% | 0.53% |
| 3-Year Total Dividends | $2.37 | $25.80 |
| Ex-Dividend Date | Dec 26, 2024 | Mar 17, 2025 |